Wolverine Stack Research Guide: BPC-157 + TB-500 Synergy
The Wolverine Stack pairs BPC-157 with TB-500 — two of the most-studied peptides in preclinical tissue repair literature. Here is why they are studied together.
Why these two peptides are studied together
BPC-157 and TB-500 are believed to act through distinct but complementary pathways. BPC-157 has been associated in animal models with VEGFR2 upregulation, nitric oxide modulation, and growth-hormone-receptor expression on tendon fibroblasts.
TB-500, by contrast, is a fragment of Thymosin Beta-4 that sequesters G-actin and is widely studied in the context of cell migration, angiogenesis, and corneal/dermal repair models.
Compliance reminder
The Wolverine Stack is sold for laboratory research use only. Not for human consumption, diagnosis, treatment, or cure of any disease.
Frequently asked questions
Why are BPC-157 and TB-500 studied together?
BPC-157 is associated with angiogenesis and growth-factor signaling, while TB-500 is associated with actin sequestration and cell migration. Researchers pair them to study complementary tissue-repair pathways in the same model.
What ratio appears in the published animal literature?
Published animal studies commonly report BPC-157 and TB-500 at roughly equivalent microgram amounts, though the literature varies.